In five pages this paper uses an example of the Information Technology outsourcing of Eastman Kodak as described in a Harvard Case Study in a consideration of what functions should pharmaceutical industries outsource. Five sources are cited in the bibliography.
Name of Research Paper File: MM12_PGphmou.rtf
Unformatted Sample Text from the Research Paper:
accomplished through outsourcing to contract research organizations (CROs) (Borchardt, 2000). Despite popular belief, larger companies outsource more than small companies (Borchardt, 2000). Midsize companies outsource more of their clinical studies
than either large or small companies (Borchardt, 2000). Small companies tend to outsource the toxicology and pharmacology studies that are required by regulatory agencies (Borchardt, 2000, p. 28). There
are always trade-offs and risks when a company chooses to outsource some of its business functions, some of which are: * Loss of control, someone else has the control over
the information and the process (Pankowska, 2002). * Exposure to vendor risks, including: Financial strength, Loss of commitment to outsourcing, Lack of responsiveness, Poor daily quality (Pankowska, 2002). *
Long-term flexibility (Pankowska, 2002). * Attention required by senior management (Pankowska, 2002). * The company will lose its expertise in the functions that are outsourced. The question any company must
answer is which functions would be best to outsource. This decision can only be made by determining the purpose of outsourcing. Assuming this is a large pharmaceutical company, if chemical
Research and Development functions were outsourced, the purpose would be to allow the company to accelerate their drug discovery and development capabilities, to expand their capacity for research and basically,
to increase their overall productivity (Borchardt, 2000). The analysis framework used to decide which business functions to outsource is presented here. 1. Where is the company now: This requires
gathering data (PA Consulting Group, 2000). 2. Where does the company want to be now and in the future (PA Consulting Group, 2000): Are there areas the company wants to
explore in terms of discovery and research but cannot due to other functions that must be completed? 3. In terms of functions, each must be identified and determined if